logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Arash Rezazadeh Kalebasty

University of California Irvine

23H指数
211论文数
4.1K被引数
收录论文 46
发表时间
logo
Transdermal Estradiol for Treating Prostate Cancer: Revisiting Huggins and Hodges’ Revolutionary Breakthrough经皮雌二醇治疗前列腺癌：重新审视Huggins和Hodges的革命性突破
errEuropean Urology Oncology
IF9.3
err2026-09-08
err0
PREAI
errDavid J. Benjamin; Arash Rezazadeh Kalebasty
err分享
err收藏
Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System)使用FAERS（FDA不良事件报告系统）对先进前列腺癌疗法的安全性信号进行比较药物警戒分析
errCurrent Oncology
IF3.4
err2026-09-03
err0
errOAAI
errZaid Ahmed; Rashid Sayyid; Omid Yazdanpanah; Ravand Samaeekia; Arash Rezazadeh Kalebasty; David I. Lee; Mohammed Shahait
err分享
err收藏
Quality of life with EV-302 in advanced urothelial carcinoma: lessons and implicationsEV-302在晚期尿路上皮癌中的生活质量：经验与启示
errTranslational Cancer Research
IF1.7
err2026-05-01
err0
PREAI
errBenjamin, David J.; Kalebasty, Arash Rezazadeh
err分享
err收藏
Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell Carcinoma了解转移性肾细胞癌管理中患者和肿瘤科医生的选择偏好
errCancer Treatment and Research Communications
IF2.4
err2026-01-01
err0
errOAAI
errYazdanpanah, Omid; Mahadevan, Aditya; Benjamin, David J.; Vosoughi, Elham; Raad, Ali; Popal, Madina; Kongtim, Piyanuch; Mar, Nataliya; Kalebasty, Arash Rezazadeh
err分享
err收藏
De Novo high-volume metastatic prostate cancer with primary resistance to standard systemic therapy and exceptional response to PSMA-Lu177: A case reportDe Novo高体积转移性前列腺癌，对标准全身治疗原发耐药且对PSMA-Lu177有特殊反应：病例报告
errInternational Cancer Conference Journal
IF0.5
err2025-12-01
err0
PREAI
errRafizadeh, Desiree; Kaakour, D.; Sun, S.; Herman, J.; Kain, T.; Kalebasty, A. Rezazadeh
err分享
err收藏
Iptacopan in C5 blockade refractory atypical hemolytic uremic syndrome with associated Castleman's disease: case report
errBMC NEPHROLOGY
IF2.4
err2025-10-24
err0
errOAAI
errNguyen, Matthew D.; Ciurea, Stefan; Desai, Sheetal; Kalebasty, Arash Rezazadeh; Tran, Minh-Ha; Gee, Caroline; Tadros, Mina; Nguyen, Vu Q.; Patel, Samir; Selamet, Umut; Hanna, Ramy
err分享
err收藏
The Genitourinary Medical Oncology Workforce in the United States美国泌尿生殖系统肿瘤医学专业队伍
errUROLOGY
IF6.8
err2025-09-01
err0
PREAI
errBenjamin, David J.; Kalebasty, Arash Rezazadeh
err分享
err收藏
A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapyTROPHY-U-01研究（队列2）的通俗总结：在无法接受顺铂为基础化疗的转移性尿路上皮癌患者中，免疫疗法后使用sacituzumab govitecan的疗效。
errFUTURE ONCOLOGY
IF2.6
err2025-09-01
err0
errOAAI
errGrivas, Petros; Tagawa, Gurdeep; Jain, Rohit K.; Bupathi, Manojkumar; Balar, Arjun; Rezazadeh Kalebasty, Arash; George, Saby; Palmbos, Phillip; Nordquist, Luke; Petrylak, Daniel P.; Davis, Nancy; Sternberg, Cora N.; Agarwal, Neeraj; Park, Chandler; Tonelli, Julia; Zhou, Huafeng; Bangs, Rick; Loriot, Yohann
err分享
err收藏
A decade review of mental health monitoring in clinical trials for United States Food and Drug Administration-approved genitourinary cancer treatments美国食品药品监督管理局批准的泌尿生殖系统癌症治疗方法临床试验中心理健康监测的十年回顾
errBJU International
IF4.4
err2025-06-15
err0
errOAAI
errFarzad Teymouri; Parnian Jabbari; Omid Yazdanpanah; Aditya Mahadevan; Arash Rezazadeh Kalebasty; David J. Benjamin
err分享
err收藏
Precision medicine in genitourinary oncology: are we pivoting towards imprecision?泌尿生殖系统肿瘤中的精准医学：我们是否正转向不精确？
errBJU INTERNATIONAL
IF4.4
err2025-05-10
err0
PREAI
errDavid J. Benjamin; Arash Rezazadeh Kalebasty
err分享
err收藏
The Role of Ayurveda in Prostate Cancer Management阿育吠陀在前列腺癌管理中的作用
errINTEGRATIVE CANCER THERAPIES
IF2.8
err2025-03-29
err0
errOAAI
errParnian Jabbari; Omid Yazdanpanah; David J. Benjamin; Arash Rezazadeh Kalebasty
err分享
err收藏
Monitoring and reporting sexual health adverse events for genitourinary cancer therapies
errBJU INTERNATIONAL
IF4.4
err2025-03-01
err0
PREAI
errBenjamin, David J.; Loeb, Charles A.; Torrey, Robert R.; Bassett, Jeffrey C.; Yazdanpanah, Omid; Kalebasty, Arash Rezazadeh
err分享
err收藏
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy最佳患者护理实践：PSMA靶向放射性药物疗法给药
errJOURNAL OF NUCLEAR MEDICINE
IF9.1
err2024-10-03
err0
PREAI
errCalais, Jeremie; Morris, Michael J.; Kendi, Ayse Tuba; Kalebasty, Arash Rezazadeh; Tutrone, Ronald; Anderson, Michael J.; Sartor, Oliver
err分享
err收藏
Novel biomarker, ephrinB2 (B2), predicts resistance to treatment and poor overall survival (OS) metastatic urothelial carcinoma (mUC)新型生物标志物 ephrinB2 (B2) 可预测转移性尿路上皮癌 (mUC) 对治疗的抵抗性以及不良的总生存期 (OS)。
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errSadeghi, S.; Mar, N.; Tsao-Wei, D.; Siddiqi, I.; Freeman, D.; Torkko, K.; van Bokhoven, A.; Flaig, T.; Gill, P.; Kalebasty, A. Rezazadeh; Sonpavde, G. P.; Bellmunt, J.
err分享
err收藏
State of supportive care in oncology 2024: Tumor types, industry support, endpoints, and trial locations2024年肿瘤支持性护理现状：肿瘤类型、行业支持、终点指标和试验地点
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errBenjamin, D. J.; Kalebasty, A. Rezazadeh
err分享
err收藏
As seen through Hollywood's lens: Cancer in movies, 2010-2020通过好莱坞的镜头：电影中的癌症，2010-2020
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errBenjamin, D. J.; Lythgoe, M. P.; Kalebasty, A. Rezazadeh
err分享
err收藏
Sacituzumab Govitecan Demonstrates Efficacy across Tumor Trop-2 Expression Levels in Patients with Advanced Urothelial CancerSacituzumab Govitecan在晚期尿路上皮癌患者的肿瘤Trop-2表达水平上显示出疗效
errCLINICAL CANCER RESEARCH
IF10.2
err2024-08-01
err1
PREAI
errLoriot, Yohann; Balar, Arjun V.; Petrylak, Daniel P.; Kalebasty, Arash R.; Grivas, Petros; Flechon, Aude; Jain, Rohit K.; Swami, Umang; Bupathi, Manojkumar; Barthelemy, Philippe; Beuzeboc, Philippe; Palmbos, Phillip; Kyriakopoulos, Christos E.; Pouessel, Damien; Sternberg, Cora N.; Tonelli, Julia; Sierecki, Mitch; Zavodovskaya, Marianna; Elboudwarej, Emon; Diehl, Lauri; Juergensmeier, Juliane M.; Tagawa, Scott T.
err分享
err收藏
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial CarcinomaSitratinib联合Nivolumab治疗晚期或转移性尿路上皮癌患者的2期研究
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2024-08-01
err2
PREAI
errMsaouel, Pavlos; Sweis, Randy F.; Bupathi, Manojkumar; Heath, Elisabeth; Goodman Jr, Oscar B.; Hoimes, Christopher J.; Milowsky, Matthew I.; Davis, Nancy; Kalebasty, Arash Rezazadeh; Picus, Joel; Shaffer, David; Mao, Shifeng; Adra, Nabil; Yorio, Jeffrey; Gandhi, Sunil; Grivas, Petros; Siefker-Radtke, Arlene; Yang, Rui; Latven, Lisa; Olson, Peter; Chin, Curtis D.; Der-Torossian, Hirak; Mortazavi, Amir; Iyer, Gopa
err分享
err收藏
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer
errFUTURE ONCOLOGY
IF2.6
err2024-06-05
err0
PREAI
errLoriot, Yohann; Kalebasty, Arash Rezazadeh; Flechon, Aude; Jain, Rohit K.; Gupta, Sumati; Bupathi, Manojkumar; Beuzeboc, Philippe; Palmbos, Phillip; Balar, Arjun, V; Kyriakopoulos, Christos E.; Pouessel, Damien; Sternberg, Cora N.; Tonelli, Julia; Sierecki, Mitch; Zhou, Huafeng; Grivas, Petros; Barthelemy, Philippe; Bangs, Rick; Tagawa, Scott T.
err分享
err收藏
The Overall Survival Benefit in EV-302: Is Enfortumab Vedotin plus Pembrolizumab the New Frontline Standard of Care for Metastatic Urothelial Carcinoma?
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2024-06-01
err3
errOAAI
errBenjamin, David J.; Kalebasty, Arash Rezazadeh; Prasad, Vinay
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
H
Howard I. Scher
H 指数: 164 · 论文数: 1.4K
J
Johann S. de Bono
H 指数: 160 · 论文数: 2.5K
F
Fred Saad
H 指数: 127 · 论文数: 1.9K
K
Karim Fizazi
H 指数: 123 · 论文数: 1.5K
N
Nicholas J. Vogelzang
H 指数: 115 · 论文数: 1.1K
查看更多